Jason Ferrone

Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA.

Creyon Bio, Inc. is a pre-clinical stage drug development company based in San Diego, CA. The company is focused on developing precision oligonucleotide-based medicines (OBMs) such as ASOs, siRNAs, guide RNAs, RNA editing guides, mRNAs, and aptamers. Creyon Bio uses a data-first approach to generate powerful datasets and develop machine learning models to uncover the engineering principles that make precision OBMs possible for patient populations of all sizes. The CEO of the company is Christopher E Hart.

Creyon Bio, Inc. is a pre-clinical stage drug development company based in San Diego, CA. The company is focused on developing precision oligonucleotide-based medicines (OBMs) such as ASOs, siRNAs, guide RNAs, RNA editing guides, mRNAs, and aptamers. Creyon Bio uses a data-first approach to generate powerful datasets and develop machine learning models to uncover the engineering principles that make precision OBMs possible for patient populations of all sizes. The CEO of the company is Christopher E Hart.

Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA.